144 related articles for article (PubMed ID: 32706404)
1. Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Ailawadhi S; Jagannath S; Lee HC; Narang M; Rifkin RM; Terebelo HR; Durie BGM; Toomey K; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; He M; Yue L; Flick ED; Agarwal A; Abonour R;
Cancer; 2020 Oct; 126(19):4332-4340. PubMed ID: 32706404
[TBL] [Abstract][Full Text] [Related]
2. Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma.
Sweiss K; Oh A; Calip GS; Rondelli D; Patel P
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e506-e511. PubMed ID: 31231013
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States.
Saunders A; Slaff S; Subbiah K; Gu T; Ang KK; Quan MA; Rosenberg AS
Leuk Lymphoma; 2024 Jan; 65(1):109-117. PubMed ID: 37917858
[TBL] [Abstract][Full Text] [Related]
4. Connect MM Registry as a national reference for United States multiple myeloma patients.
Ailawadhi S; Jagannath S; Narang M; Rifkin RM; Terebelo HR; Toomey K; Durie BGM; Hardin JW; Gasparetto CJ; Wagner L; Omel JL; Kumar V; Yue L; Kitali A; Agarwal A; Abonour R;
Cancer Med; 2020 Jan; 9(1):35-42. PubMed ID: 31701679
[TBL] [Abstract][Full Text] [Related]
5. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry.
Rifkin RM; Jagannath S; Durie BGM; Narang M; Terebelo HR; Gasparetto CJ; Toomey K; Hardin JW; Wagner L; Parikh K; Abouzaid S; Srinivasan S; Kitali A; Zafar F; Abonour R
Clin Ther; 2018 Jul; 40(7):1193-1202.e1. PubMed ID: 30007443
[TBL] [Abstract][Full Text] [Related]
7. Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
Gasparetto C; Jagannath S; Rifkin RM; Durie BGM; Narang M; Terebelo HR; Toomey K; Hardin JW; Wagner L; Ailawadhi S; Omel JL; Srinivasan S; Dhalla M; Catamero D; Kitali A; Agarwal A; Abonour R;
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):149-157. PubMed ID: 34588149
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.
Lupak O; Xiaoxia H; Xie P; Thanikachalam K; Jabbour-Aida H; Farhan S; Emole J
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e680-e685. PubMed ID: 34148850
[TBL] [Abstract][Full Text] [Related]
9. Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM.
Jagannath S; Abonour R; Durie BGM; Narang M; Terebelo HR; Gasparetto CJ; Toomey K; Hardin JW; Wagner L; Agarwal A; Srinivasan S; Kitali A; Flick ED; Sturniolo M; Rifkin RM
Blood Adv; 2018 Jul; 2(13):1608-1615. PubMed ID: 29986853
[TBL] [Abstract][Full Text] [Related]
10. Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.
Bhatnagar V; Wu Y; Goloubeva OG; Ruehle KT; Milliron TE; Harris CG; Rapoport AP; Yanovich S; Sausville EA; Baer MR; Badros AZ
Cancer; 2015 Apr; 121(7):1064-70. PubMed ID: 25469920
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.
van de Donk NW; van der Holt B; Minnema MC; Vellenga E; Croockewit S; Kersten MJ; von dem Borne PA; Ypma P; Schaafsma R; de Weerdt O; Klein SK; Delforge M; Levin MD; Bos GM; Jie KG; Sinnige H; Coenen JL; de Waal EG; Zweegman S; Sonneveld P; Lokhorst HM
Lancet Haematol; 2018 Oct; 5(10):e479-e492. PubMed ID: 30290905
[TBL] [Abstract][Full Text] [Related]
12. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H
Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032
[TBL] [Abstract][Full Text] [Related]
13. Development of a prognostic model for overall survival in multiple myeloma using the Connect
Terebelo HR; Abonour R; Gasparetto CJ; Toomey K; Durie BGM; Hardin JW; Jagannath S; Wagner L; Narang M; Flick ED; Srinivasan S; Yue L; Kitali A; Agarwal A; Rifkin RM;
Br J Haematol; 2019 Dec; 187(5):602-614. PubMed ID: 31382320
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
Kim SJ; Kim K; Kim BS; Jo DY; Kang HJ; Kim JS; Mun YC; Kim CS; Sohn SK; Eom HS; Kwak JY; Shim H; Yoon HJ; Jin JY; Min CK; Shin H; Won JH; Lee JJ; Kwon JH; Joo YD; Do YR; Kim SH; Oh S; Suh C; Lee J; Yoon SS; Kim MK; Bang SM; Ryoo HM; Kim BS; Kim H; Kim HJ; Kim YS; Park CW; Lee GW; Shin HJ; Park SK; Park JS; Kim HY; Lee DS; Lee JH;
Acta Haematol; 2009; 122(4):200-10. PubMed ID: 19887776
[TBL] [Abstract][Full Text] [Related]
15. Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States.
Richter J; Pan D; Salinardi T; Rice MS
EJHaem; 2023 Nov; 4(4):984-994. PubMed ID: 38024614
[TBL] [Abstract][Full Text] [Related]
16. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
[TBL] [Abstract][Full Text] [Related]
17. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
[TBL] [Abstract][Full Text] [Related]
18. High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis.
Jain T; Sonbol MB; Firwana B; Kolla KR; Almader-Douglas D; Palmer J; Fonseca R
Biol Blood Marrow Transplant; 2019 Feb; 25(2):239-247. PubMed ID: 30244101
[TBL] [Abstract][Full Text] [Related]
19. Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.
Giaccone L; Evangelista A; Patriarca F; Sorasio R; Pini M; Carnevale-Schianca F; Festuccia M; Brunello L; Zallio F; Maffini E; Omedé P; Bringhen S; Mordini N; Fanin R; Ciccone G; Boccadoro M; Bruno B
Biol Blood Marrow Transplant; 2018 Jan; 24(1):189-193. PubMed ID: 28987930
[TBL] [Abstract][Full Text] [Related]
20. Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States.
Buck T; Hartley-Brown MA; Efebera YA; Milner CP; Zonder JA; Richardson PG; Salinardi T; Rice MS
Haematologica; 2023 Nov; ():. PubMed ID: 38031762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
